Lv4
440 积分 2022-10-30 加入
Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials
10小时前
已完结
High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial
10小时前
已完结
Moderately Hypofractionated Once-Daily Compared With Twice-Daily Thoracic Radiation Therapy Concurrently With Etoposide and Cisplatin in Limited-Stage Small Cell Lung Cancer: A Multicenter, Phase II, Randomized Trial
10小时前
已完结
Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey
3个月前
已完结
Novel pharmacotherapeutic options for the treatment of postural orthostatic tachycardia syndrome
4个月前
已完结
Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
4个月前
已完结
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)
5个月前
已完结
Durvalumab with chemoradiotherapy for limited-stage small-cell lung cancer
5个月前
已完结
Diagnosis and management of ANCA-associated vasculitis
9个月前
已完结
SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection
1年前
已完结
皖公网安备34019202002308
